Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
399.50    -1.50 (-0.37%)
Bid:
400.00
Ask:
400.50
Spread: 0.50 (0.125%)
Market Cap: £1.81b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Kepler Trust Intelligence: New Research

23 Oct 2025 07:00

RNS Number : 4404E
HgCapital Trust PLC
23 October 2025
Β 

HgCapital Trust: New Research

23/10/2025

HGT offers a unique tech exposure that has delivered strong long-term NAV growth…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

Β 

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

Β 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRAPPGRAUUPAGWP
Date   Source Headline
30th Oct 20175:48 pmRNSDirector/PDMR Shareholding
11th Oct 20174:54 pmRNSHolding(s) in Company
9th Oct 20173:45 pmRNSHolding(s) in Company
9th Oct 20177:04 amRNSPerformance at month end
11th Sep 20177:00 amRNSInterim Report and Accounts
11th Sep 20177:00 amRNSInterim Results - Six Months Ended 30 June 2017
24th Aug 20174:14 pmRNSHolding(s) in Company
21st Aug 20171:00 pmRNSSale of Sequel
29th Jun 20177:00 amRNSHgCapital leads buyout of Visma
26th Jun 20173:39 pmRNSDirector Declaration
19th Jun 20177:00 amRNSHgCapital announces an investment in Esendex
14th Jun 201710:55 amRNSHgCapital Trust announces sale of Zitcom
7th Jun 20177:00 amRNSPerformance at month end
1st Jun 201711:57 amRNSHgCapital announces sale of Parts Alliance
26th May 20175:00 pmRNSHolding(s) in Company
26th May 20179:21 amRNSHolding(s) in Company
18th May 20177:00 amRNSDirector/PDMR Shareholding
10th May 20175:32 pmRNSResult of AGM
9th May 20177:00 amRNSPerformance at month end
26th Apr 20175:36 pmRNSDirector/PDMR Shareholding
26th Apr 20177:00 amRNSHgCapital announces sale of QUNDIS to KALORIMETA
12th Apr 20174:46 pmRNSHolding(s) in Company
11th Apr 20175:27 pmRNSHolding(s) in Company
7th Apr 20177:00 amRNSPerformance at month end
4th Apr 20177:00 amRNSInvestment in Mitratech
6th Mar 201712:10 pmRNSReplacement Annual Financial Report
6th Mar 20177:00 amRNSAnnual Financial Report
6th Mar 20177:00 amRNSFull Year Results
16th Feb 20179:29 amRNSFinal closing of HgCapital 8 and Mercury 2
30th Jan 20175:35 pmRNSHolding(s) in Company
30th Jan 20179:18 amRNSHolding(s) in Company
30th Jan 20177:00 amRNSHgCapital announces sale of Zenith to Bridgepoint
26th Jan 201710:50 amRNSHolding(s) in Company
25th Jan 20173:41 pmRNSHolding(s) in Company
20th Jan 20173:37 pmRNSHolding(s) in Company
8th Dec 20167:00 amRNSPerformance at month end
17th Nov 20167:00 amRNSHgCapital announces investment in fundinfo
8th Nov 20167:10 amRNSHgCapital announces investment in Evaluate
8th Nov 20167:00 amRNSPerformance at month end
25th Oct 20169:15 amRNSHolding(s) in Company
12th Oct 20167:00 amRNSHgCapital announces investment in Baldwins
7th Oct 20167:00 amRNSPerformance at month end
19th Sep 20167:45 amRNSHgCapital announces an Investment in Visma BPO
19th Sep 20167:00 amRNSHgCapital announces sale of P&I
12th Sep 20167:00 amRNSInterim Report and Accounts
12th Sep 20167:00 amRNSInterim Results
9th Sep 20165:44 pmRNSHolding(s) in Company
6th Sep 201611:49 amRNSDirector/PDMR Shareholding
5th Sep 20165:07 pmRNSDirector/PDMR Shareholding
11th Aug 20165:12 pmRNSHgCapital announces investment in Mobyt

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.